Also, as a result of the presentation by our partner, Taiho Pharmaceutical, of an application to commercialise Yondelis® for treating soft tissue sarcoma, in the Japanese regulator conducted a documentary inspection of the quality system, 36 | 2015 CORPORATE SOCIAL RESPONSIBILITY REPORT facilities and equipment, and manufacturing process for trabectedin, with entirely satisfactory results.